spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Venture Capital

 HSMN NewsFeed - 24 May 2021
Eliem Therapeutics Announces $60 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 20 May 2021
BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 May 2021
Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 18 May 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 13 May 2021
Healionics Raises $4.7M Equity Round to Support Commercialization of Stargraft Vascular Graft
Devices Venture Capital
 HSMN NewsFeed - 13 May 2021
SpliSense Secures $28.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 May 2021
Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 May 2021
BridGene Biosciences Announces $12 Million Series A Financing to Advance the Company's Proprietary Chemoproteomic Platform and Pipeline of Oncology Programs
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Apr 2021
Blue Therapeutics announces Series A raise
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2021
Capsida Biotherapeutics Debuts with $140 Million of Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2021
Microsure raises € 2.7 million under new leadership for the further development and clinical roll-out of the MUSA microsurgery robot assistant
Devices Surgery Venture Capital
 HSMN NewsFeed - 28 Apr 2021
Caresyntax Raises $100 Million to Make Surgery Smarter and Safer
Devices Surgery Venture Capital
 HSMN NewsFeed - 20 Apr 2021
PyrAmes Raises $6 Million in Series A Financing
Devices Monitoring Cardiology Venture Capital
 HSMN NewsFeed - 20 Apr 2021
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 15 Apr 2021
Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Devices Venture Capital
 HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Apr 2021
Memic Innovative Surgery Raises $96 Million
Devices Surgery Venture Capital
 HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel
Older Venture Capital stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.